Clinical Trial Update: BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit [Phase 1]

View source ↗

Summary

Phase 1 trial update of BI-2536 in patients with advanced solid tumors. The study has completed after repeated administration in patients who demonstrated clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• BI-2536

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED